Testing effectiveness (Phase 2)Study completedNCT01845987
What this trial is testing
The Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar Pustulosis
Who this might be right for
Palmoplantaris Pustulosis
Janssen Pharmaceutical K.K. 49